Annual SGA
$229.39 M
+$44.25 M+23.90%
December 31, 2024
Summary
- As of March 8, 2025, ARQT annual SGA is $229.39 million, with the most recent change of +$44.25 million (+23.90%) on December 31, 2024.
- During the last 3 years, ARQT annual SGA has risen by +$168.42 million (+276.23%).
- ARQT annual SGA is now at all-time high.
Performance
ARQT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$57.61 M
-$1.21 M-2.06%
December 31, 2024
Summary
- As of March 8, 2025, ARQT quarterly SGA is $57.61 million, with the most recent change of -$1.21 million (-2.06%) on December 31, 2024.
- Over the past year, ARQT quarterly SGA has increased by +$8.93 million (+18.35%).
- ARQT quarterly SGA is now -2.06% below its all-time high of $58.82 million, reached on September 30, 2024.
Performance
ARQT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.32 B
-$140.04 M-3.35%
December 31, 2024
Summary
- As of March 8, 2025, ARQT TTM SGA is -$4.32 billion, with the most recent change of -$140.04 million (-3.35%) on December 31, 2024.
- Over the past year, ARQT TTM SGA has dropped by -$4.51 billion (-2433.31%).
- ARQT TTM SGA is now -17695.36% below its all-time high of -$24.28 million.
Performance
ARQT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ARQT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | +18.4% | -2433.3% |
| 3 y3 years | +276.2% | +21.0% | -2590.0% |
| 5 y5 years | +3370.4% | +21.0% | -2590.0% |
ARQT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +276.2% | -2.1% | +207.6% | -242.0% | at low |
| 5 y | 5-year | at high | +3370.4% | -2.1% | +2475.2% | -3500.7% | at low |
| alltime | all time | at high | >+9999.0% | -2.1% | +9406.1% | <-9999.0% | at low |
Arcutis Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $229.39 M(+23.9%) | $57.61 M(-2.1%) | $229.39 M(+4.1%) |
| Sep 2024 | - | $58.82 M(+1.1%) | $220.46 M(+5.4%) |
| Jun 2024 | - | $58.17 M(+6.2%) | $209.24 M(+6.2%) |
| Mar 2024 | - | $54.79 M(+12.6%) | $197.02 M(+6.4%) |
| Dec 2023 | $185.15 M(+51.6%) | $48.67 M(+2.3%) | $185.15 M(+6.7%) |
| Sep 2023 | - | $47.59 M(+3.6%) | $173.49 M(+7.5%) |
| Jun 2023 | - | $45.96 M(+7.1%) | $161.37 M(+12.8%) |
| Mar 2023 | - | $42.92 M(+15.9%) | $143.04 M(+17.1%) |
| Dec 2022 | $122.12 M(+100.3%) | $37.02 M(+4.4%) | $122.12 M(+17.6%) |
| Sep 2022 | - | $35.47 M(+28.4%) | $103.83 M(+22.4%) |
| Jun 2022 | - | $27.62 M(+25.5%) | $84.83 M(+23.8%) |
| Mar 2022 | - | $22.01 M(+17.5%) | $68.52 M(+12.4%) |
| Dec 2021 | $60.97 M | $18.73 M(+13.7%) | $60.97 M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $16.47 M(+45.6%) | $48.93 M(+28.7%) |
| Jun 2021 | - | $11.31 M(-21.7%) | $38.02 M(+17.6%) |
| Mar 2021 | - | $14.45 M(+116.1%) | $32.32 M(+51.5%) |
| Dec 2020 | $21.34 M(+222.8%) | $6.69 M(+20.3%) | $21.34 M(+26.4%) |
| Sep 2020 | - | $5.56 M(-1.0%) | $16.88 M(+23.9%) |
| Jun 2020 | - | $5.62 M(+61.9%) | $13.62 M(+46.0%) |
| Mar 2020 | - | $3.47 M(+55.1%) | $9.33 M(+41.1%) |
| Dec 2019 | $6.61 M(+268.2%) | $2.24 M(-2.7%) | $6.61 M(+32.8%) |
| Sep 2019 | - | $2.30 M(+73.7%) | $4.98 M(+85.9%) |
| Jun 2019 | - | $1.32 M(+76.8%) | $2.68 M(+97.7%) |
| Mar 2019 | - | $749.00 K(+23.6%) | $1.35 M(+123.6%) |
| Dec 2018 | $1.79 M(+158.3%) | $606.00 K | $606.00 K |
| Dec 2017 | $695.00 K | - | - |
FAQ
- What is Arcutis Biotherapeutics annual SGA?
- What is the all time high annual SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual SGA year-on-year change?
- What is Arcutis Biotherapeutics quarterly SGA?
- What is the all time high quarterly SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
- What is Arcutis Biotherapeutics TTM SGA?
- What is the all time high TTM SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM SGA year-on-year change?
What is Arcutis Biotherapeutics annual SGA?
The current annual SGA of ARQT is $229.39 M
What is the all time high annual SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual SGA is $229.39 M
What is Arcutis Biotherapeutics annual SGA year-on-year change?
Over the past year, ARQT annual SGA has changed by +$44.25 M (+23.90%)
What is Arcutis Biotherapeutics quarterly SGA?
The current quarterly SGA of ARQT is $57.61 M
What is the all time high quarterly SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly SGA is $58.82 M
What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
Over the past year, ARQT quarterly SGA has changed by +$8.93 M (+18.35%)
What is Arcutis Biotherapeutics TTM SGA?
The current TTM SGA of ARQT is -$4.32 B
What is the all time high TTM SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM SGA is -$24.28 M
What is Arcutis Biotherapeutics TTM SGA year-on-year change?
Over the past year, ARQT TTM SGA has changed by -$4.51 B (-2433.31%)